No Data
No Data
Monthly Information on Share Capital and Company Voting Rights
Analysts Offer Insights on Healthcare Companies: Ardelyx (ARDX), Oric Pharmaceuticals (ORIC) and Cellectis SA (CLLS)
AstraZeneca Concludes Equity Investment in Cellectis
Express News | Cellectis Shares Are Trading Higher After the Company Announced the Completion of the Additional Equity Investment by AstraZeneca
AstraZeneca Invests $140M in Cellectis, Raising Stake to 44%
AstraZeneca Secures 44% Stake in French Biotech Cellectis
AstraZeneca (AZN.L, AZN.ST) said Monday it completed its equity investment in Cellectis (ALCLS.PA) and secured a 44% stake in the clinical-stage French biotechnology company.
No Data